Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Frankfurt - Delayed Quote EUR

Cellectis S.A. (ZVA.F)

Compare
1.2780
-0.0080
(-0.62%)
As of 8:09:45 AM GMT+1. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
29,072
755
19,171
30,346
51,057
Cost of Revenue
--
737
1,772
1,844
1,951
Gross Profit
--
18
17,399
28,502
49,106
Operating Expense
106,788
97,320
107,065
131,984
91,418
Operating Income
-78,453
-97,302
-89,666
-103,482
-42,312
Net Non Operating Interest Income Expense
1,885
-2,812
-14,994
-3,011
-680
Other Income Expense
-8,240
-16,352
6,060
9,741
-10,590
Pretax Income
-84,808
-116,466
-98,600
-96,752
-53,582
Tax Provision
-508
371
87
--
--
Net Income Common Stockholders
-84,478
-101,059
-106,139
-114,197
-81,074
Diluted NI Available to Com Stockholders
-84,478
-101,059
-106,139
-114,197
-81,074
Basic EPS
-1.17
-1.77
-2.33
-1.91
-1.91
Diluted EPS
-1.17
-1.77
-2.33
-1.91
-1.91
Basic Average Shares
81,855.5620
57,012.8150
45,553.2190
42,447.1200
42,503.4470
Diluted Average Shares
81,855.5620
57,012.8150
45,553.2190
42,447.1200
42,590.4070
Total Operating Income as Reported
-78,453
-97,302
-89,666
-103,481
-42,311
Total Expenses
107,525
98,057
108,837
133,828
93,369
Net Income from Continuing & Discontinued Operation
-84,478
-101,059
-106,139
-114,197
-81,074
Normalized Income
-76,287.3576
-97,187
-95,339
-95,580
-26,582
Interest Income
9,158
3,614
1,120
719
1,392
Interest Expense
7,091
5,307
3,787
4,171
2,407
Net Interest Income
1,885
-2,812
-14,994
-3,011
-680
EBIT
-77,717
-111,159
-94,813
-92,581
-51,175
EBITDA
-58,518
-92,636
-76,378
-78,425
-43,341
Reconciled Cost of Revenue
--
737
1,772
1,844
1,951
Reconciled Depreciation
19,199
18,523
18,435
14,156
7,834
Net Income from Continuing Operation Net Minority Interest
-84,478
-109,451
-90,794
-85,839
-37,172
Total Unusual Items Excluding Goodwill
-8,240
-16,352
6,060
9,741
-10,590
Total Unusual Items
-8,240
-16,352
6,060
9,741
-10,590
Normalized EBITDA
-50,278
-76,284
-82,438
-88,166
-32,751
Tax Rate for Calcs
0
0.0003
0.0003
--
--
Tax Effect of Unusual Items
-49.3576
-4,088
1,515
--
--
12/31/2020 - 2/20/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BV3A.F Bavarian Nordic A/S
7.25
-2.68%
 
22Z.F Zealand Pharma A/S
80.30
-0.93%
 
4R0.F Oxford Nanopore Technologies plc
1.1800
-8.10%
 
AYJ.F Valneva SE
3.2820
-3.47%
 
CVAC CureVac N.V.
3.0800
-0.65%
 
RVMD Revolution Medicines, Inc.
38.34
-5.89%
 
MESO Mesoblast Limited
15.41
-10.15%
 
ALNY Alnylam Pharmaceuticals, Inc.
243.53
-1.30%
 
AXSM Axsome Therapeutics, Inc.
127.15
-0.31%
 
REGN Regeneron Pharmaceuticals, Inc.
684.87
-1.99%